High Chlamydia burden promotes tumor necrosis factor-dependent reactive arthritis in SKG mice

Arthritis and Rheumatology

Volumn 67, Issue 6, 2015, Pages 1535-1547

  Baillet, Athan C ^a   Rehaume, Linda M ^a   Benham, Helen ^a   O'Meara, Connor P ^b   Armitage, Charles W ^b   Ruscher, Roland ^a   Brizard, Geraldine ^c   Harvie, Marina C G ^b   Velasco, Jared ^a   Hansbro, Phillip M ^d   Forrester, John V ^c,e   Degli Esposti, Mariapia A ^c,f   Beagley, Kenneth W ^b   Thomas, Ranjeny ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c LIONS EYE INSTITUTE   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BETA GLUCAN; DOXYCYCLINE; ETANERCEPT; GAMMA INTERFERON; INTERLEUKIN 17; OUTER MEMBRANE PROTEIN; PROTEIN KINASE ZAP 70; RIFAMPICIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; BACTERIUM ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CHLAMYDIA MURIDARUM; CHLAMYDIASIS; CONJUNCTIVITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE SEVERITY; ENTHESITIS; FEMALE; HIND PAW; HISTOLOGY; INFECTION CONTROL; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REACTIVE ARTHRITIS; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFECTION; SACROILIITIS; SPONDYLARTHRITIS; SYNOVITIS; T CELL DEPLETION; VAGINITIS; ANIMAL; BAGG ALBINO MOUSE; GENITAL TRACT INFECTION; IMMUNOLOGY; INBRED MOUSE STRAIN; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, BACTERIAL; ARTHRITIS, REACTIVE; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FEMALE; INFLAMMATORY BOWEL DISEASES; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; PSORIASIS; REPRODUCTIVE TRACT INFECTIONS; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA; VAGINOSIS, BACTERIAL;

EID: 84929878759     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39041     Document Type: Article

References (50)

1. Rich E, Hook EW III, Alarcon GS, Moreland LW., Reactive arthritis in patients attending an urban sexually transmitted diseases clinic. Arthritis Rheum 1996; 39: 1172-7.
2. Meyer A, Chatelus E, Wendling D, Berthelot JM, Dernis E, Houvenagel E, et al, on behalf of the Club Rhumatisme et Inflammation. Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. Arthritis Rheum 2011; 63: 1274-80.
3. Bas S, Kvien TK, Buchs N, Fulpius T, Gabay C., Lower level of synovial fluid interferon-γ in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis. Rheumatology (Oxford) 2003; 42: 461-7.
4. Beckett EL, Phipps S, Starkey MR, Horvat JC, Beagley KW, Foster PS, et al., TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life. PloS One 2012; 7: e39460.
5. Nanagara R, Li F, Beutler A, Hudson A, Schumacher HR Jr., Alteration of Chlamydia trachomatis biologic behavior in synovial membranes: suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum 1995; 38: 1410-7.
6. Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T, et al., T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007; 204: 41-7.
7. O'Meara CP, Armitage CW, Harvie MC, Timms P, Lycke NY, Beagley KW,. Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology. PloS One 2013; 8: e61962.
8. Cunningham KA, Carey AJ, Lycke N, Timms P, Beagley KW., CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosa. J Reprod Immunol 2009; 81: 34-8.
9. + regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 2011; 34: 409-21.
10. + cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J Immunol 2009; 183: 7631-4.
11. Ito T, Hoshiai K, Tanabe K, Nakamura A, Funamoto K, Aoyagi A, et al., Maternal undernutrition with vaginal inflammation impairs the neonatal oligodendrogenesis in mice. Tohoku J Exp Med 2011; 223: 215-22.
12. Carey AJ, Cunningham KA, Hafner LM, Timms P, Beagley KW., Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice. Immunol Cell Biol 2009; 87: 337-43.
13. Pal S, Peterson EM, de la Maza LM., New murine model for the study of Chlamydia trachomatis genitourinary tract infections in males. Infect Immun 2004; 72: 4210-6.
14. Moazed TC, Kuo CC, Grayston JT, Campbell LA., Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998; 177: 1322-5.
15. Hough AJ Jr, Rank RG,. Induction of arthritis in C57B1/6 mice by chlamydial antigen: effect of prior immunization or infection. Am J Pathol 1988; 130: 163-72.
16. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, et al., Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005; 11: 43-9.
17. Zhang X, Gao L, Lei L, Zhong Y, Dube P, Berton MT, et al., A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum. J Immunol 2009; 183: 1291-300.
18. Nakamura T, Toda M, Ohbayashi M, Ono SJ., Detailed criteria for the assessment of clinical symptoms in a new murine model of severe allergic conjunctivitis. Cornea 2003; 22: S13-8.
19. Ruutu M, Thomas G, Steck R, Degli-Esposti MA, Zinkernagel MS, Alexander K, et al., β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice. Arthritis Rheum 2012; 64: 2211-22.
20. Pate MS, Hedges SR, Sibley DA, Russell MW, Hook EW III, Mestecky J., Urethral cytokine and immune responses in Chlamydia trachomatis-infected males. Infect Immun 2001; 69: 7178-81.
21. Igietseme JU, Perry LL, Ananaba GA, Uriri IM, Ojior OO, Kumar SN, et al., Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun 1998; 66: 1282-6.
22. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, et al., Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001; 276: 31332-9.
23. Yoshitomi H, Sakaguchi N, Kobayashi K, Brown GD, Tagami T, Sakihama T, et al., A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 2005; 201: 949-60.
24. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al., Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003; 426: 454-60.
25. Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE, Byrne GI., Dissemination of Chlamydia trachomatis chronic genital tract infection in γ interferon gene knockout mice. Infect Immun 1997; 65: 2145-52.
26. Perry LL, Feilzer K, Caldwell HD., Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-γ-dependent and-independent pathways. J Immunol 1997; 158: 3344-52.
27. Scurlock AM, Frazer LC, Andrews CW Jr, O'Connell CM, Foote IP, Bailey SL, et al., Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect Immun 2011; 79: 1349-62.
28. Darville T, O'Neill JM, Andrews CW Jr, Nagarajan UM, Stahl L, Ojcius DM., Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003; 171: 6187-97.
29. Gerard HC, Carter JD, Hudson AP., Chlamydia trachomatis is present and metabolically active during the remitting phase in synovial tissues from patients with chronic Chlamydia-induced reactive arthritis. Am J Med Sci 2013; 346: 22-5.
30. Zhang Y, Wang H, Ren J, Tang X, Jing Y, Xing D, et al., IL-17A synergizes with IFN-γ to upregulate iNOS and NO production and inhibit chlamydial growth. PloS One 2012; 7: e39214.
31. He X, Nair A, Mekasha S, Alroy J, O'Connell CM, Ingalls RR., Enhanced virulence of Chlamydia muridarum respiratory infections in the absence of TLR2 activation. PloS One 2011; 6: e20846.
32. Yamazaki S, Okada K, Maruyama A, Matsumoto M, Yagita H, Seya T., TLR2-dependent induction of IL-10 and Foxp3+CD25+CD4+ regulatory T cells prevents effective anti-tumor immunity induced by Pam2 lipopeptides in vivo. PloS One 2011; 6: e18833.
33. Tanaka S, Maeda S, Hashimoto M, Fujimori C, Ito Y, Teradaira S, et al., Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function. J Immunol 2010; 185: 2295-305.
34. Appel H, Wu P, Scheer R, Kedor C, Sawitzki B, Thiel A, et al., Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis. J Rheumatol 2011; 38: 2445-51.
35. Wencker M, Turchinovich G, Di Marco Barros R, Deban L, Jandke A, Cope A, et al., Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness. Nat Immunol 2014; 15: 80-7.
36. Miyairi I, Byrne GI., Chlamydia and programmed cell death. Curr Opin Microbiol 2006; 9: 102-8.
37. Carter JD, Espinoza LR, Inman RD, Sneed KB, Ricca LR, Vasey FB, et al., Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum 2010; 62: 1298-307.
38. Rehaume LM, Mondot S, Aguirre de Carcer D, Velasco J, Benham H, Hasnain SZ, et al., ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice. Arthritis Rheumatol 2014; 66: 2780-92.
39. Wilkinson NZ, Kingsley GH, Jones HW, Sieper J, Braun J, Ward ME., The detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritides using a nested, broad-range polymerase chain reaction. Rheumatology (Oxford) 1999; 38: 260-6.
40. Schumacher HR Jr, Arayssi T, Crane M, Lee J, Gerard H, Hudson AP, et al., Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects. Arthritis Rheum 1999; 42: 1281-4.
41. Carter JD, Gerard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, et al., Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 2009; 60: 1311-6.
42. Gerard HC, Freise J, Wang Z, Roberts G, Rudy D, Krauss-Opatz B, et al., Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect 2002; 4: 13-22.
43. Gerard HC, Whittum-Hudson JA, Schumacher HR, Hudson AP., Synovial Chlamydia trachomatis up regulates expression of a panel of genes similar to that transcribed by Mycobacterium tuberculosis during persistent infection. Ann Rheum Dis 2006; 65: 321-7.
44. Inman RD, Chiu B, Johnston ME, Falk J., Molecular mimicry in Reiter's syndrome: cytotoxicity and ELISA studies of HLA-microbial relationships. Immunology 1986; 58: 501-6.
45. Inman RD, Chiu B., Early cytokine profiles in the joint define pathogen clearance and severity of arthritis in Chlamydia-induced arthritis in rats. Arthritis Rheum 2006; 54: 499-507.
46. Hannu T., Reactive arthritis. Best Pract Res Clinical Rheumatol 2011; 25: 347-57.
47. Davis P, Stein M, Latif A, Emmanuel J., Acute arthritis in Zimbabwean patients: possible relationship to human immunodeficiency virus infection. J Rheumatol 1989; 16: 346-8.
48. Barber CE, Kim J, Inman RD, Esdaile JM, James MT., Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis. J Rheumatol 2013; 40: 916-28.
49. Dreses-Werringloer U, Padubrin I, Jurgens-Saathoff B, Hudson AP, Zeidler H, Kohler L., Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother 2000; 44: 3288-97.
50. Dreses-Werringloer U, Padubrin I, Zeidler H, Kohler L., Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 2001; 45: 3001-8.